KK
TEVA icon

KLP Kapitalforvaltning’s Teva Pharmaceuticals TEVA Stock Holding History

KLP Kapitalforvaltning’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
416,759
+30,600
+8% +$1.02M 0.05% 330
2026
Q1 		$11.6M Buy
386,159
+16,800
+5% +$540K 0.05% 337
2025
Q4 		$11.5M Buy
369,359
+3,000
+0.8% +$73.9K 0.04% 334
2025
Q3 		$7.4M Hold
366,359
– – 0.03% 424
2025
Q2 		$6.14M Buy
366,359
+7,300
+2% +$118K 0.03% 446
2025
Q1 		$5.52M Sell
359,059
-48,000
-12% -$857K 0.03% 464
2024
Q4 		$8.97M Buy
+407,059
New +$7.41M 0.04% 369

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

KLP Kapitalforvaltning's TEVA Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Teva Pharmaceuticals (TEVA) stake by 7.9% in Q2 2026, buying an estimated $1.02M and bringing the position to 416,759 shares worth $14.1M. The position accounts for 0.05% of the portfolio, ranked #330.

KLP Kapitalforvaltning first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • KLP Kapitalforvaltning held 416,759 shares of Teva Pharmaceuticals worth $14.1M as of Q2 2026.
  • KLP Kapitalforvaltning bought 30,600 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.02M.
  • Teva Pharmaceuticals made up 0.05% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #330 holding.
  • KLP Kapitalforvaltning first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.